Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep

Peta Grigsby, Jonathan J. Hirst, Jean Pierre Scheerlinck, David J. Phillips, Graham Jenkin

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

A link between intrauterine infection and premature labor is widely accepted, yet the fetal inflammatory responses to such infections are not well understood. Our aim was to use a sheep model in which an inflammatory state was induced by lipopoly-saccharide (LPS) administration during pregnancy to the maternal systemic, intra-amniotic or extra-amniotic compartments. Fetal and maternal blood gases and uterine electromyographic activity along with fetal and maternal circulating concentrations of prostaglandins PGE2 and PGFM, cortisol, and interleukin-6 were determined. Maternal systemic LPS treatment resulted in mild maternal hypoxemia, a rise in temperature, greater fetal hypoxemia, and a marked rise in fetal cortisol and PGE2 concentrations that persisted for 48 h. Intra-amniotic administration of LPS at doses higher than those used systemically caused an increase in fetal cortisol and PGE2 concentrations as well as a rise in uterine activity, but these were lesser in magnitude. Extraamniotic LPS administration caused no overt fetal or maternal inflammatory responses. We conclude that maternal LPS treatment markedly elevated fetal cortisol and PGE2 concentrations. This may be a potential protective mechanism that aids the fetus in the event of premature delivery. The attenuated fetal response to intra-amniotic LPS treatment, despite the much higher dose used, may support a role for the amniotic fluid in protecting the fetus from endotoxin exposure during pregnancy.

Original languageEnglish (US)
Pages (from-to)1695-1702
Number of pages8
JournalBiology of Reproduction
Volume68
Issue number5
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Lipopolysaccharides
Sheep
Mothers
Dinoprostone
Hydrocortisone
Fetus
Pregnancy
Premature Obstetric Labor
Amniotic Fluid
Infection
Fetal Blood
Endotoxins
Prostaglandins
Interleukin-6
Gases
Temperature

Keywords

  • Cortisol
  • Cytokines
  • Parturition
  • Placenta
  • Uterus

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Embryology

Cite this

Grigsby, P., Hirst, J. J., Scheerlinck, J. P., Phillips, D. J., & Jenkin, G. (2003). Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep. Biology of Reproduction, 68(5), 1695-1702. https://doi.org/10.1095/biolreprod.102.009688

Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep. / Grigsby, Peta; Hirst, Jonathan J.; Scheerlinck, Jean Pierre; Phillips, David J.; Jenkin, Graham.

In: Biology of Reproduction, Vol. 68, No. 5, 01.05.2003, p. 1695-1702.

Research output: Contribution to journalArticle

Grigsby, P, Hirst, JJ, Scheerlinck, JP, Phillips, DJ & Jenkin, G 2003, 'Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep', Biology of Reproduction, vol. 68, no. 5, pp. 1695-1702. https://doi.org/10.1095/biolreprod.102.009688
Grigsby, Peta ; Hirst, Jonathan J. ; Scheerlinck, Jean Pierre ; Phillips, David J. ; Jenkin, Graham. / Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep. In: Biology of Reproduction. 2003 ; Vol. 68, No. 5. pp. 1695-1702.
@article{a18879885c0d46c889423567158afb42,
title = "Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep",
abstract = "A link between intrauterine infection and premature labor is widely accepted, yet the fetal inflammatory responses to such infections are not well understood. Our aim was to use a sheep model in which an inflammatory state was induced by lipopoly-saccharide (LPS) administration during pregnancy to the maternal systemic, intra-amniotic or extra-amniotic compartments. Fetal and maternal blood gases and uterine electromyographic activity along with fetal and maternal circulating concentrations of prostaglandins PGE2 and PGFM, cortisol, and interleukin-6 were determined. Maternal systemic LPS treatment resulted in mild maternal hypoxemia, a rise in temperature, greater fetal hypoxemia, and a marked rise in fetal cortisol and PGE2 concentrations that persisted for 48 h. Intra-amniotic administration of LPS at doses higher than those used systemically caused an increase in fetal cortisol and PGE2 concentrations as well as a rise in uterine activity, but these were lesser in magnitude. Extraamniotic LPS administration caused no overt fetal or maternal inflammatory responses. We conclude that maternal LPS treatment markedly elevated fetal cortisol and PGE2 concentrations. This may be a potential protective mechanism that aids the fetus in the event of premature delivery. The attenuated fetal response to intra-amniotic LPS treatment, despite the much higher dose used, may support a role for the amniotic fluid in protecting the fetus from endotoxin exposure during pregnancy.",
keywords = "Cortisol, Cytokines, Parturition, Placenta, Uterus",
author = "Peta Grigsby and Hirst, {Jonathan J.} and Scheerlinck, {Jean Pierre} and Phillips, {David J.} and Graham Jenkin",
year = "2003",
month = "5",
day = "1",
doi = "10.1095/biolreprod.102.009688",
language = "English (US)",
volume = "68",
pages = "1695--1702",
journal = "Biology of Reproduction",
issn = "0006-3363",
publisher = "Society for the Study of Reproduction",
number = "5",

}

TY - JOUR

T1 - Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep

AU - Grigsby, Peta

AU - Hirst, Jonathan J.

AU - Scheerlinck, Jean Pierre

AU - Phillips, David J.

AU - Jenkin, Graham

PY - 2003/5/1

Y1 - 2003/5/1

N2 - A link between intrauterine infection and premature labor is widely accepted, yet the fetal inflammatory responses to such infections are not well understood. Our aim was to use a sheep model in which an inflammatory state was induced by lipopoly-saccharide (LPS) administration during pregnancy to the maternal systemic, intra-amniotic or extra-amniotic compartments. Fetal and maternal blood gases and uterine electromyographic activity along with fetal and maternal circulating concentrations of prostaglandins PGE2 and PGFM, cortisol, and interleukin-6 were determined. Maternal systemic LPS treatment resulted in mild maternal hypoxemia, a rise in temperature, greater fetal hypoxemia, and a marked rise in fetal cortisol and PGE2 concentrations that persisted for 48 h. Intra-amniotic administration of LPS at doses higher than those used systemically caused an increase in fetal cortisol and PGE2 concentrations as well as a rise in uterine activity, but these were lesser in magnitude. Extraamniotic LPS administration caused no overt fetal or maternal inflammatory responses. We conclude that maternal LPS treatment markedly elevated fetal cortisol and PGE2 concentrations. This may be a potential protective mechanism that aids the fetus in the event of premature delivery. The attenuated fetal response to intra-amniotic LPS treatment, despite the much higher dose used, may support a role for the amniotic fluid in protecting the fetus from endotoxin exposure during pregnancy.

AB - A link between intrauterine infection and premature labor is widely accepted, yet the fetal inflammatory responses to such infections are not well understood. Our aim was to use a sheep model in which an inflammatory state was induced by lipopoly-saccharide (LPS) administration during pregnancy to the maternal systemic, intra-amniotic or extra-amniotic compartments. Fetal and maternal blood gases and uterine electromyographic activity along with fetal and maternal circulating concentrations of prostaglandins PGE2 and PGFM, cortisol, and interleukin-6 were determined. Maternal systemic LPS treatment resulted in mild maternal hypoxemia, a rise in temperature, greater fetal hypoxemia, and a marked rise in fetal cortisol and PGE2 concentrations that persisted for 48 h. Intra-amniotic administration of LPS at doses higher than those used systemically caused an increase in fetal cortisol and PGE2 concentrations as well as a rise in uterine activity, but these were lesser in magnitude. Extraamniotic LPS administration caused no overt fetal or maternal inflammatory responses. We conclude that maternal LPS treatment markedly elevated fetal cortisol and PGE2 concentrations. This may be a potential protective mechanism that aids the fetus in the event of premature delivery. The attenuated fetal response to intra-amniotic LPS treatment, despite the much higher dose used, may support a role for the amniotic fluid in protecting the fetus from endotoxin exposure during pregnancy.

KW - Cortisol

KW - Cytokines

KW - Parturition

KW - Placenta

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=0037408202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037408202&partnerID=8YFLogxK

U2 - 10.1095/biolreprod.102.009688

DO - 10.1095/biolreprod.102.009688

M3 - Article

C2 - 12606477

AN - SCOPUS:0037408202

VL - 68

SP - 1695

EP - 1702

JO - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 5

ER -